. 2007 Dec;27(10):1297–1310. doi: 10.1111/j.1478-3231.2007.01613.x

Table 3.

Sustained response to consensus interferon/ribavirin vs. interferon-α-2b/ribavirin by hepatitis C virus genotype, ethnicity, gender and body weight

	Consensus interferon/ribavirin (n=63)	interferon-α-2b/ribavirin (n=65)	P-value
All genotypes
<800 000 IU/mL	12/21 (57%)	14/26 (54%)	0.82
≥800 000 IU/mL	24/42 (57%)	12/39 (31%)	0.017^*
Genotype 1
<800 000 IU/mL	5/13 (38%)	9/20 (45%)	0.70
≥800 000 IU/mL	13/28 (46%)	4/28 (14%)	0.0089^*
Genotype-non 1
<800 000 IU/mL	7/8 (88%)	5/6 (83%)	0.82
≥800 000 IU/mL	11/14 (79%)	8/11 (73%)	0.70
Race
White	28/42 (67%)	16/40 (40%)	0.015^*
Non-white	8/21 (38%)	10/25 (40%)	0.89
Sex
Men	19/43 (44%)	17/44 (39%)	0.59
Women	17/20 (85%)	9/21 (43%)	0.005^*
Weight
<75 kg	15/19 (79%)	10/20 (50%)	0.059
≥75 kg	21/44 (48%)	16/45 (36%)	0.24

Statistically significant.